XLV vs SPY26-Year Performance Comparison

Health Care vs S&P 500 — backtested 19992024

SPY wins$76,190 vs $67,678 on $10,000 over 26 years
XLVHealth Care
Final value$67,678
CAGR+7.6%
Max drawdown-27.2%
Best year+41% (2013)
Years won14 of 26
SPYS&P 500
Final value$76,190
CAGR+8.1%
Max drawdown-37.6%
Best year+32% (2013)
Years won12 of 26

Growth of $10,000

19992024
XLVSPY
$42k$79k199920042009201420192024
XLV$67,678
SPY$76,190
50/50 mix$75,823

50/50 blend: $75,823 (+8.1%/yr CAGR)

Splitting equally between XLV and SPY would have landed between the two — slightly lower CAGR than SPY but less volatility. Try a custom split →

Year-by-year: XLV vs SPY

YearXLVSPYWinner
2024+2.6%+23.3%SPY
2023+2.1%+26.3%SPY
2022-2.1%-18.2%XLV
2021+26.1%+28.7%SPY
2020+13.4%+18.4%SPY
2019+20.8%+31.5%SPY
2018+6.5%-4.4%XLV
2017+22.1%+21.8%XLV
2016-2.7%+12.0%SPY
2015+6.9%+1.4%XLV
2014+25.3%+13.7%XLV
2013+41.4%+32.4%XLV
2012+17.4%+16.0%XLV
2011+10.2%+2.1%XLV
2010+3.2%+15.1%SPY
2009+19.0%+26.5%SPY
2008-22.8%-37.0%XLV
2007+7.3%+5.5%XLV
2006+6.6%+15.8%SPY
2005+7.6%+4.9%XLV
2004+1.6%+10.9%SPY
2003+17.0%+28.7%SPY
2002-17.7%-22.1%XLV
2001-11.6%-11.9%XLV
2000+28.4%-9.1%XLV
1999-4.9%+21.0%SPY

More comparisons

Build your portfolio

Mix XLV + SPY with custom allocations

Try a 70/30 or 40/60 split — or add up to 3 more ETFs. See exactly how your custom portfolio would have performed.

Open Portfolio Builder →

Past performance does not guarantee future results.